Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is This the End of Steven Cohen’s Insider Trading Battle?

Steven Cohen insider trading: It’s no secret that Steven Cohen and SAC Capital are going through a rough patch, mainly because of the insider trading lawsuit initiated by the Securities and Exchange Commission earlier in July. Now, federal prosecutors, with U.S. attorney Preet Bharara in front, demand that the fund plead guilty and pay a $2 billion fine, according to the New York Times’ DealBook. Cohen now has a couple of weeks to reach a decision; a rejection could result in an even higher fine further down the road.

Steven Cohen

Aside from insider trading, prosecutors also accused SAC of “mixing its illegally obtained insider-trading profits with the rest of its money, thus tainting all of its funds,” a DealBook source stated. The government, consequently, now wants to prosecute all of the money held by SAC. After managing around $15 billion at the beginning of 2013, now almost all outsiders have requested their investments back.

If Cohen agrees to pay the fine, he will still have a sizable chunk of assets within the SAC Capital structure.

In July, the SEC initiated charges against Cohen for failing to supervise two senior employees who allegedly engaged in insider trading. SAC and its affiliate, CR Intrinsic, held long positions in two publicly traded companies, Elan Corporation, plc (ADR) (NYSE:ELN) and Wyeth Limited (NSE:WYETH), which reportedly collaborated on a clinical trial of a drug used to treat Alzheimer’s.

In 2008, another portfolio manager of SAC disclosed to Cohen information regarding the financial results of Dell Inc. (NASDAQ:DELL), which it owned shares of at the time. According to the received information, the gross profit margin range of Dell would be below what analysts forecasted, which could have led to the decline of Dell’s stock. After receiving the news, Cohen sold his entire $11 million stake held in Dell.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!